VolitionRX (VNRX) Earnings Date & Reports

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis... Show more

Industry: #Medical Or Nursing Services

Get AI intraday signals

A.I. Advisor

published Earnings

VNRX is expected to report earnings to fall 53.82% to -39 cents per share on November 12

Q3'26

Est.

$-0.39

Q2'26

Missed

by $0.24

Q1'26

Missed

by $0.93

Q4'25

Missed

by $0.95

Q3'25

Missed

by $0.01

The last earnings report on August 13 showed earnings per share of -85 cents, missing the estimate of -60 cents. With 1.38M shares outstanding, the current market capitalization sits at 7.60M.

View a ticker or compare two or three

VNRX

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for VNRX